Automating Subthalamic Deep Brain Stimulation Programming with Evoked Resonant Neural Activity in Parkinson's Disease
Movement Disorders · 2026-07 · 41 (7) · 1847-1855
DOI: 10.1002/mds.70318 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, online erschienen am 15.04.2026. Verfasst von Kanae J Nagao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medical Bionics Department, The University of Melbourne, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Deep Brain Stimulation, Parkinson Disease, Subthalamic Nucleus, Evoked Potentials. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University of Melbourne.
Abstract (Originalsprache)
Background
Optimal outcomes from subthalamic nucleus deep brain stimulation (STN‐DBS) for Parkinson's disease (PD) depend on accurate stimulation of an ideal functional target within the dorsolateral STN. Clinical programming is heuristic, and objective methods are needed to improve efficiency and consistency.
Objectives
This study aimed to investigate the feasibility and acute motor benefit of STN‐DBS programming, guided by intraoperatively recorded evoked resonant neural activity (ERNA) in patients with PD.
Methods
We assessed 12 patients with anatomically well‐placed leads, 4–6 months following STN‐DBS. The worst hemibody was tested off‐medication. Acute motor benefit was double‐blind assessed for three programming configurations: (i) chronic expert clinician settings, (ii) imaging guided, and (iii) an ERNA automated algorithm. We also compared therapeutic and side effect thresholds and the spatial distribution of fractionated current.
Results
ERNA programming improved hemibody Movement Disorder Society‐Unified Parkinson's Disease Rating Scale‐Part III scores by 75.7% (median) compared with off‐stimulation. This was not different from imaging (81.6%, P = 0.19) or clinician programming (68.8%, P = 0.33). Therapeutic thresholds ( P = 0.90) and side effect thresholds ( P = 0.57) did not differ across conditions. ERNA programming was 0.8–1 mm ventral and 0.3 mm posterior to imaging and clinician programming.
Conclusions
A programming algorithm based solely on ERNA achieved acute motor efficacy and tolerability equivalent to expert clinical and imaging‐based approaches. ERNA recordings took
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Bionics Department, The University of Melbourne, Melbourne, Victoria, Australia.
- Florey Department of Neuroscience and Mental Health, The University of Melbourne, Melbourne, Victoria, Australia.
- Neurology Department, Austin Health, Melbourne, Victoria, Australia.
- Deep Brain Stimulation Technologies Pty Ltd, Melbourne, Victoria, Australia.
- Florey Institute of Neuroscience, Melbourne, Victoria, Australia.
- Bionics Institute, East Melbourne, Victoria, Australia.
ORCID-Profile: Kanae J Nagao, San San Xu
Förderung
- University of Melbourne
Zitieren
APA
Nagao, K. J., Perera, T., Petoe, M., Lee, W. L., Xu, S. S., Lawson, K., Moorhead, A., McDermott, H., Bulluss, K., & Thevathasan, W. (2026). Automating Subthalamic Deep Brain Stimulation Programming with Evoked Resonant Neural Activity in Parkinson's Disease. Movement Disorders, 41(7), 1847-1855. https://doi.org/10.1002/mds.70318
Vancouver
Nagao KJ, Perera T, Petoe M, Lee WL, Xu SS, Lawson K, et al. Automating Subthalamic Deep Brain Stimulation Programming with Evoked Resonant Neural Activity in Parkinson's Disease. Movement Disorders. 2026;41(7):1847-1855. doi:10.1002/mds.70318
BibTeX
@article{Nagao2026,
author = {Nagao, Kanae J and Perera, Thushara and Petoe, Matthew and Lee, Wee-Lih and Xu, San San and Lawson, Kiaran and Moorhead, Ashton and McDermott, Hugh and Bulluss, Kristian and Thevathasan, Wesley},
title = {Automating Subthalamic Deep Brain Stimulation Programming with Evoked Resonant Neural Activity in Parkinson's Disease},
journal = {Movement Disorders},
year = {2026},
volume = {41},
number = {7},
pages = {1847--1855},
doi = {10.1002/mds.70318}
}
EUVIMED